Pacemakers

This channel includes news and new technology innovations for pacemakers used to treat bradycardia.

First implant of Amvia Sky in Canada performed at the Centre Hospitalier de l'Université de Montréal
News | Implantable Cardiac Monitor (ICM)
Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP

July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P ...

Home July 11, 2024
Home
Dr. Rahul Doshi leads ‘BACKBEAT’ clinical trial to prevent strokes and heart attacks by precisely timing heartbeats
News | Cardiovascular Clinical Studies
HonorHealth Research Institute Study Uses New Programing for Pacemakers to Control High Blood Pressure Without Additional Drugs

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market
News | FDA
Elutia Announces FDA Clearance of EluPro: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

June 17, 2024 — Elutia Inc., a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting ...

Home June 17, 2024
Home
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM Subcutaneous Implantable Defibrillator and EMPOWER Leadless Pacemaker
News | Cardiovascular Clinical Studies
MODULAR ATP Study of the mCRM System Meets Primary Safety and Efficacy Endpoints

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

Home May 18, 2024
Home
A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart
News | Cardiovascular Clinical Studies
Transcatheter Valve Replacement Outcomes Similar to Surgery in Long-Term Analysis

May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the ...

Home May 15, 2024
Home
‘Scattered Denial’ documents how long-term exposure to radiation in catheterization labs may cause cancer
News | Radiation Dose Management
Documentary Led by HonorHealth Research Institute Focuses on Injuries to Doctors and Nurses Working in Cardiology

May 7, 2024 — HonorHealth Research Institute’s David G. Rizik, M.D., narrates and is a co-producer of a documentary ...

Home May 07, 2024
Home
UC San Diego Health is the first in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with abnormal heart rhythms
News | Pacemakers
UC San Diego Health First in Region to Implant Dual Chamber, Leadless Pacemaker

March 26, 2024 — UC San Diego Health is the first health system in San Diego to successfully implant the world’s first ...

Home March 26, 2024
Home
Biotronik Launches Its Complete Conduction System Pacing (CSP) Solution Consisting of the World’s First Approved CSP System Alongside Comprehensive Training and Expert Support
News | Pacemakers
Biotronik Introduces World’s First and Only System CE Approved for Left Bundle Branch Area Pacing (LBBAP)

March 15, 2024 —  Following the recent CE approval of the Solia S lead1 for LBBAP, BIOTRONIK proudly announces the world ...

Home March 15, 2024
Home
Biotronik Launches Its Complete Conduction System Pacing (CSP) Solution Consisting of the World’s First Approved CSP System Alongside Comprehensive Training and Expert Support
News | Pacemakers
Biotronik Introduces World’s First and Only System CE Approved for Left Bundle Branch Area Pacing (LBBAP)

March 15, 2024 —  Following the recent CE approval of the Solia S lead1 for LBBAP, Biotronik announces the world’s first ...

Home March 15, 2024
Home
NCDR’s CV ASC Registry Suite follows increases in ambulatory cardiac procedures, provides benchmarks
News | ACC
First-of-its-kind ACC Registry Tracks Cardiac Procedures Performed in Ambulatory Surgical Settings

February 14, 2024 — The American College of Cardiology’s newest registry offers data-driven insights on cardiac ...

Home February 14, 2024
Home
Orchestra BioMed and Medtronic, Inc., have an exclusive strategic collaboration for development and commercialization of AVIM therapy for hypertensive pacemaker population, which is estimated to be more than 750,000 patients annually worldwide
News | Hypertension
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk ...

Home January 19, 2024
Home
It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of Bruce Wilkoff, MD, FHRS
News | EP Lab
In Memoriam: Bruce Wilkoff, MD, FHRS

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership
News | Pacemakers
Medtronic Receives CE Mark for its Next Generation Micra Leadless Pacing Systems

January 5, 2024 — Medtronic, a global leader in healthcare technology, today announced it has received CE (ConformitĂ© ...

Home January 05, 2024
Home
TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, announced the successful implantation of its Topaz transfemoral tricuspid heart valve replacement system (“Topaz”) in a patient with a pacemaker at the University Medical Center of Mainz, Germany.
News | Heart Valve Technology
TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
News | Hypertension
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients

September 20, 2023 — Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to ...

Home September 20, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now